Numerous studies have suggested that tissue factor (TF) may play an important role in the pathogenesis of hypercoagulable states in patients with cancer (Rao, 1992), and TF expression has been confirmed in some cancer tissues by immunohistochemistry (Callander et al, 1992; Ueno et al, 2000). This evidence concerns the gene TF and cancer.